Aspirin metabolism may hold key to preventing preeclampsia
NCT ID NCT06802861
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how pregnant women at risk for preeclampsia process aspirin and how that relates to signs of metabolic problems. Researchers will measure aspirin byproducts in blood and urine, along with other health markers, in 50 women. The goal is to better understand why aspirin helps prevent preeclampsia in some but not others.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aspirin
- What this could lead to
- If successful, this study could help doctors better understand how aspirin works to prevent preeclampsia, potentially leading to more personalized prevention plans.
- What could go wrong
- This is a small, early-stage observational study with only 50 participants, so results may not apply to all pregnant women. It is not testing a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Tennessee Medical Center
RECRUITINGKnoxville, Tennessee, 37920, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Could a smart ring unlock secrets of pregnancy health?